ebomi
Colour theme
Sign in
Insider · CIK 0001752139

Becker Daniel J.

CIK 0001752139 Name as filed on the most recent filing

Filed as Becker Daniel J. (10)

14 transaction lines · from 10 filings · filed 2018-09-20 to 2024-07-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

14 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-07-17 Acelyrin, Inc.
SLRN 		S, Open-market sale 1 disposed 6.86 6.86 Form 4, filing 0001962918-24-000099
2023-05-09 Acelyrin, Inc.
SLRN 		P, Open-market purchase 3,000 acquired 18.00 54,000.00 Form 4, filing 0001209191-23-028874
2021-06-01 Day One Biopharmaceuticals, Inc.
DAWN 		P, Open-market purchase 5,000 acquired 16.00 80,000.00 Form 4, filing 0001209191-21-037023
2020-11-19 Pandion Therapeutics, Inc.
PAND 		P, Open-market purchase 197,716 acquired 15.12 2,989,465.92 Form 4, filing 0000899243-20-031941
2020-11-18 Pandion Therapeutics, Inc.
PAND 		P, Open-market purchase 14,197 acquired 15.26 216,646.22 Form 4, filing 0000899243-20-031744
2020-11-17 Pandion Therapeutics, Inc.
PAND 		P, Open-market purchase 13,027 acquired 15.43 201,006.61 Form 4, filing 0000899243-20-031744
2020-11-17 Pandion Therapeutics, Inc.
PAND 		P, Open-market purchase 2,170 acquired 14.63 31,747.10 Form 4, filing 0000899243-20-031744
2020-07-21 Pandion Therapeutics, Inc.
PAND 		P, Open-market purchase 722,222 acquired 18.00 12,999,996.00 Form 4, filing 0000899243-20-019874
2020-07-21 Pandion Therapeutics, Inc.
PAND 		P, Open-market purchase 1,000 acquired 18.00 18,000.00 Form 4, filing 0000899243-20-019874
2019-11-20 Principia Biopharma Inc.
PRNB 		P, Open-market purchase 55,000 acquired 29.94 1,646,700.00 Form 4, filing 0001209191-19-057879
2019-10-29 Principia Biopharma Inc.
PRNB 		P, Open-market purchase 9,196 acquired 33.98 312,477.32 Form 4, filing 0001209191-19-054503
2019-10-28 Principia Biopharma Inc.
PRNB 		P, Open-market purchase 68,404 acquired 33.41 2,285,548.65 Form 4, filing 0001209191-19-054503
2019-10-18 Principia Biopharma Inc.
PRNB 		P, Open-market purchase 535,000 acquired 28.00 14,980,000.00 Form 4, filing 0001209191-19-053770
2018-09-18 Principia Biopharma Inc.
PRNB 		P, Open-market purchase 270,000 acquired 17.00 4,590,000.00 Form 4, filing 0001209191-18-051835

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 13
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Becker Daniel J., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001752139

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.